- +1 (212)-695-1962
- info@adrita.life
- Gurugram, Shushant lok
Hormone replacement therapy (HRT) is a treatment used to relieve symptoms associated with menopause by replacing hormones that the body produces in lower amounts during this transition. It can help manage symptoms such as hot flashes, night sweats and vaginal dryness, and can also help protect bone health in appropriate women.
In clinical literature, HRT is also commonly called menopausal hormone therapy (MHT). Both terms refer to hormone treatment used during perimenopause and menopause, although the specific treatment depends on a woman’s symptoms, medical history, age and stage of menopause.
HRT is not one standard treatment for everyone. It is available in different forms and combinations, and the right option depends on individual needs and an assessment of potential benefits and risks.
During perimenopause and menopause, the ovaries produce less estrogen. Fluctuating and declining hormone levels can contribute to symptoms that affect sleep, mood, temperature regulation, sexual health and everyday quality of life.
HRT replaces estrogen to relieve symptoms caused by declining estrogen levels. Depending on whether a woman has a uterus, she may also need a second hormone called a progestogen to protect the lining of the uterus.
HRT may be prescribed to:
HRT is not suitable or necessary for every woman experiencing menopause. Treatment decisions should take into account symptoms, health history, individual risk factors and preferences. [1, 2]
HRT is the most effective treatment for hot flashes and night sweats associated with menopause. For women whose symptoms are troublesome, treatment can make a meaningful difference to sleep, daily functioning and quality of life.
The potential benefits include:
Relief from hot flashes and night sweats: Systemic HRT can reduce the frequency and severity of these symptoms.
Improved sleep: Sleep may improve when night sweats and other menopause-related symptoms are controlled.
Relief from vaginal and urinary symptoms: Vaginal estrogen can help with dryness, irritation and painful sex, as well as some urinary symptoms associated with menopause.
Bone health: Systemic HRT helps prevent bone loss and reduces the risk of fractures while treatment is being used.
Hormone replacement after early menopause: For women with premature ovarian insufficiency or early menopause, hormone therapy can replace estrogen lost earlier than expected and help protect long-term health.
The benefits depend on the treatment used, the woman’s age and health, the symptoms being treated and the timing of treatment. HRT is not recommended solely to prevent cardiovascular disease, dementia or ageing-related changes. [1, 2]
HRT is available in different forms, depending on which hormones are needed and how they are delivered. The options below explain the main treatment types used in India and what each is generally intended to do. Availability of individual products may vary.
| Type of treatment | What it means | What it is used for |
|---|---|---|
| Estrogen-only HRT | Estrogen is given without a progestogen. | Relieves symptoms such as hot flashes and night sweats, and helps protect bone health. Generally prescribed after a total hysterectomy, when the uterus has been removed. |
| Combined HRT | Estrogen is combined with a progestogen, such as micronised progesterone or dydrogesterone. | Relieves menopausal symptoms while protecting the uterine lining when the uterus is still present. |
| Sequential combined HRT | Estrogen is taken continuously, with a progestogen added for part of the treatment cycle. | Often used during perimenopause or when periods have not fully stopped. A scheduled withdrawal bleed usually occurs. |
| Continuous combined HRT | Estrogen and progestogen are taken together continuously. | Generally used after menopause, with the aim of avoiding regular withdrawal bleeding. |
| Oral HRT tablets | Hormones are taken by mouth, as estrogen-only or combined preparations. | A convenient way to treat systemic symptoms such as hot flashes and night sweats. Oral estrogen may not be the preferred route for women with certain clotting risk factors. |
| Transdermal estrogen: gels and patches | Estrogen is absorbed through the skin rather than taken orally. | Treats systemic symptoms. It is associated with a lower risk of venous blood clots than oral estrogen and may be preferred for some women with relevant risk factors. |
| Low-dose vaginal estrogen | Estrogen is applied locally using a vaginal preparation, such as a cream. | Helps relieve vaginal dryness, irritation, painful sex and some urinary symptoms. It does not usually treat hot flashes or night sweats. |
| Tibolone | A synthetic medicine with estrogen-like, progestogenic and androgen-like effects. | An alternative for selected postmenopausal women; it is not the same as conventional estrogen-and-progestogen HRT. |
| Raloxifene and other selective estrogen receptor modulators (SERMs) | Medicines that act on estrogen receptors differently in different tissues. | Used for selected indications, particularly bone health, rather than as a general treatment for menopausal symptoms. |
The type of hormone and the way it is delivered are two separate considerations. For example, estrogen-only versus combined HRT describes which hormones are used, while oral versus transdermal describes how the hormones enter the body.
Women who still have a uterus generally need adequate progestogen alongside systemic estrogen to protect the uterine lining. Low-dose vaginal estrogen is different: it acts primarily on local vaginal and urinary symptoms and is not a substitute for systemic HRT when symptoms such as hot flashes and night sweats need treatment. Some women may use vaginal estrogen alongside systemic HRT, depending on their symptoms and clinical assessment.
Testosterone is not a routine treatment for general menopausal symptoms. It may be considered in selected cases of persistent low sexual desire after an appropriate specialist assessment. It should not be presented as a standard HRT option.
HRT may be appropriate if menopausal symptoms are affecting your comfort, sleep, work, relationships or quality of life. It may also be recommended in situations such as premature ovarian insufficiency or early menopause, when replacing estrogen can be particularly important.
Your clinician will consider several factors before recommending treatment.
The type of symptoms you experience helps determine which treatment may be useful. For example, hot flashes and night sweats generally require consideration of systemic treatment, whereas vaginal dryness alone may respond to low-dose vaginal estrogen.
HRT can also be considered during perimenopause. You do not necessarily need to wait until your periods have stopped completely before discussing treatment.
For healthy women who are younger than 60 or within about 10 years of menopause, the overall benefit–risk balance of systemic HRT is often more favourable when treatment is appropriate. Starting systemic HRT later, particularly more than 10 years after menopause or after age 60, generally requires greater caution because certain risks increase with age and time since menopause. These are general considerations, not rigid cut-offs for every individual. [1, 3]
Your clinician will consider factors such as your personal history of breast or other hormone-sensitive cancers, unexplained vaginal bleeding, blood clots, stroke, cardiovascular disease, liver disease and other relevant conditions. Family history and other individual risk factors may also influence the decision.
Some conditions mean systemic HRT should generally be avoided; others may require specialist advice or a different treatment approach.
HRT can be effective, but it is important to understand its possible side effects and longer-term risks. These vary depending on the type of hormones used, the route of administration, the duration of treatment, the woman’s age and her health history.
Some women experience breast tenderness, bloating, headaches, nausea, mood changes or irregular bleeding, particularly when starting treatment or changing the regimen. Side effects may settle over time, but persistent or troublesome symptoms should be discussed with the prescribing clinician. Adjusting the preparation or route may help.
Breast cancer risk depends partly on the type of HRT used and how long it is taken. Combined estrogen-and-progestogen HRT is associated with an increase in breast cancer risk that generally becomes greater with longer duration of use. Estrogen-only HRT has a different risk profile, but the evidence cannot be applied to every individual or every treatment context.
This is one reason the choice of HRT and the decision to continue it should be reviewed periodically, rather than relying on a single rule for all women. [1, 3]
Oral systemic estrogen is associated with a higher risk of venous blood clots than transdermal estrogen. The risk varies according to the route of administration and individual factors such as age, weight, previous clotting events and other medical conditions.
The risk of stroke also needs to be considered, particularly when systemic HRT is started at an older age or many years after menopause. Transdermal estrogen may be preferred for some women at increased risk of blood clots, but suitability must be assessed individually. [1, 2]
Systemic HRT may not be suitable for women with certain medical histories, including some hormone-sensitive cancers, unexplained vaginal bleeding, previous or current blood clots, stroke, significant liver disease or other serious conditions. The decision depends on the specific diagnosis and circumstances; some women may need advice from a specialist.
If systemic HRT is not suitable, other treatments are available for managing menopausal symptoms.
There is no single test that determines whether HRT is right for every woman. The assessment usually begins with a detailed discussion of symptoms, menstrual history, medical conditions, family history, medicines and personal preferences.
Depending on your circumstances, your clinician may recommend:
For otherwise healthy women aged 45 or older with typical menopausal symptoms, hormone blood tests are not usually needed to diagnose natural menopause. Tests should be guided by the clinical situation rather than ordered routinely for everyone. [1, 2]
HRT can be considered when menopausal symptoms become troublesome, including during perimenopause. The timing depends on your symptoms, stage of menopause, health history and treatment goals.
There is no single maximum duration that applies to every woman. Some women use HRT for a relatively short period to manage symptoms; others may benefit from continuing for longer after a regular review of the benefits and risks. The decision should be revisited periodically as symptoms, age and health circumstances change.
If you stop HRT, symptoms may return. The decision to stop, reduce or change treatment should be discussed with your clinician. There is no universal requirement to stop at a particular age, but ongoing treatment should be reviewed regularly. [1, 2]
When menopause occurs earlier than expected, the implications can extend beyond symptom relief.
Premature ovarian insufficiency (POI) refers to loss or significant reduction of ovarian function before age 40. Early menopause occurs before age 45. Menopause can also occur after surgery to remove both ovaries or following certain medical treatments.
In these situations, hormone therapy may be recommended to replace estrogen until around the usual age of natural menopause, unless there is a reason it should not be used. This can help manage symptoms and protect bone health, with potential broader health benefits. The treatment plan depends on the cause of early estrogen loss, whether the uterus is present and the woman’s individual circumstances. [1]
HRT is not the only way to manage menopause symptoms. Alternatives depend on the symptoms you want to address and may include:
Non-hormonal prescription treatments: Certain medicines can help manage hot flashes and night sweats when HRT is unsuitable or not preferred.
Menopause-specific cognitive behavioural therapy (CBT): This may help with the impact of symptoms such as sleep difficulties and hot flashes, either alongside other treatment or on its own.
Vaginal moisturisers and lubricants: These can help relieve vaginal dryness and discomfort during sex. Vaginal estrogen may still be an option for some women even when systemic HRT is not suitable, but this requires individual assessment.
Lifestyle measures: Regular physical activity, adequate sleep, a balanced diet, limiting personal triggers and avoiding smoking can contribute to overall health and help some women manage symptoms.
The most appropriate option depends on your symptoms, medical history and preferences. A clinician can help you compare the expected benefits and limitations of each approach. [1, 2]
HRT can be an effective treatment for menopausal symptoms when prescribed to an appropriate patient. Its benefits and risks vary according to age, time since menopause, type of treatment, route of administration, duration and medical history. A personalised assessment is essential.
There is no single best type of HRT for everyone. The choice depends on your symptoms, whether you still have a uterus, whether you are in perimenopause or postmenopause, your health history and your preferences. A clinician can help identify the most suitable option.
Treatment options in India include estrogen tablets, transdermal estrogen preparations such as gels and patches, combined estrogen-and-progestogen treatments, and low-dose vaginal estrogen. Selected alternatives such as tibolone may also be considered. The availability of individual products can vary.
Estrogen-only HRT contains estrogen without a progestogen and is generally used after a total hysterectomy. Combined HRT contains estrogen and a progestogen; the progestogen protects the uterine lining when the uterus is still present.
Yes. HRT may be considered during perimenopause if symptoms are troublesome. The regimen needs to account for menstrual status and the possibility of pregnancy, as HRT itself is not a contraceptive.
Weight and body composition often change during midlife and menopause, but there is no strong evidence that HRT consistently causes significant weight gain. Changes in weight can have several contributing factors, including ageing, activity, sleep and metabolic changes.
The risk depends on the type of HRT, duration of use and individual circumstances. Combined HRT is associated with an increase in breast cancer risk that generally rises with longer use. Estrogen-only HRT has a different risk profile. Discuss your personal and family history with your clinician before deciding.
Transdermal estrogen is associated with a lower risk of venous blood clots than oral estrogen and may be preferred for some women with relevant risk factors. However, the safest option depends on your overall health and treatment needs.
Estrogen-only HRT is generally an option after a total hysterectomy because the uterus is no longer present. Certain circumstances, including the type of surgery and medical history, may affect the decision, so treatment should still be individualised.
There is no single duration that is right for everyone. Some women use HRT for a limited period, while others continue longer if the benefits outweigh the risks. Regular reviews help determine whether to continue, adjust or stop treatment.
Some women stop HRT without gradually reducing it, while others prefer to taper their treatment. Symptoms may return after stopping, whether you stop suddenly or gradually. Discuss the approach with your clinician so you can plan for symptom management if needed.
Low-dose vaginal estrogen is intended mainly for local symptoms such as vaginal dryness, irritation and discomfort during sex. It has much lower systemic absorption than systemic HRT and does not usually relieve hot flashes or night sweats.
Hormone therapy is often recommended for women who experience premature ovarian insufficiency or early menopause, and after removal of both ovaries, until around the usual age of natural menopause, unless contraindicated. It can help manage symptoms and protect bone health. Your clinician will assess the benefits and risks in your circumstances.
Choosing HRT involves more than deciding whether to take hormones. The type of treatment, the way it is given, your medical history and your individual goals all matter.
At Adrita Menopause Wellness, Dr. Ankita Mittal can help you understand your symptoms, discuss appropriate treatment options and assess whether HRT may be suitable for you.
If menopause symptoms are affecting your quality of life, book a consultation to discuss your concerns and develop a personalised care plan.
Adrita Menopause Wellness is Gurgaon’s top clinic dedicated to supporting women through menopause, perimenopause, and midlife health transitions.
